JP
John Paulson (Paulson & Co) disclosed new in AMICUS THERAPEUTIC
John Paulson (Paulson & Co) filed a 13F change in AMICUS THERAPEUTIC (03152W109) on 2026-05-15, covering period end 2026-03-31.
Action
New
Capital
$468,504 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.